News and analysis on disease research and diagnostics.
The deals are with institutional investors and more than 1 million American Depositary Shares will be offered at A$1.75 per ADS.
Under the guidance, only the laboratory that developed the test can perform it if the lab is CLIA-certified to perform high-complexity tests.
If the proposal is finalized, the tests will go through a less burdensome process to obtain marketing clearances.
Bringing testing closer to patients could be helpful, provided enough tests and instruments can be manufactured and distributed.
The partners will launch Zymo's DreamPrep NAP workstation to streamline DNA/RNA extraction for high-complexity testing labs running COVID-19 assays.
